(300261) today announced that the company raised investment project with an annual output of 217 tons of pharmaceutical intermediates due to the introduction of precision instruments imported, long cycle, affecting the completion of the project, the company is currently completing the project Final accounts, to prepare the relevant acceptance procedures, is expected to postpone until April 30 to complete the final accounts.

Yaben Chemical said that the production line has entered the commissioning stage, some projects have begun trial production, and some product output, production capacity in the gradual release process. Therefore, the extension of the company's business does not constitute a substantial impact.